da-kuk The artificial intelligence sector encompassed almost a third of all global venture capital funding, representing five out of six rounds in the second quarter, according to a DataTrek Morning Briefing. Overall global venture capital funding picked up in the second quarter, after the lowest two quarters since 2021. VentureContinue Reading
peterschreiber.media Mizuho started coverage of Neumora Therapeutics (NASDAQ:NMRA) with an outperform rating, stating it sees 50%+ upside to the stock if the company reports positive Phase 3 data for its lead drug navacaprant in the treatment of major depressive disorder. The investment bank noted the Phase 3 data is expectedContinue Reading
RHJ/iStock via Getty Images Vale (NYSE:VALE) has selected veteran mining executive Shaun Usmar to take the helm of its base metals division, Bloomberg reported Wednesday. Usmar would bring more than 30 years of industry experience to the position, with his latest role as founder and CEO of streaming company TripleContinue Reading
The Technology Select Sector SPDR Fund ETF (NYSEARCA:XLK), which tracks S&P 500’s information technology sector, gained 8.38% so far this quarter, outperforming the 4.56% rise in the broader S&P500 Index. The information technology sector, which consists of stocks including Nvidia (NVDA), First Solar (FSLR), and Apple (AAPL) led the packContinue Reading
rafal_olechowski Carisma Therapeutics (NASDAQ:CARM) climbed ~29% premarket Friday after the cell therapy developer said it would receive $2M for discovering a cancer drug candidate as part of a collaboration with Moderna (NASDAQ:MRNA). Nominating the first development candidate under the partnership, the company said that the unnamed drug targets Glypican-3, aContinue Reading
MicroStockHub X4 Pharmaceuticals (NASDAQ:XFOR) traded sharply lower on Thursday after the biotech updated data from an ongoing Phase 2 trial for its lead candidate mavorixafor in chronic neutropenia (CN), a rare blood disorder. Citing a May 24 data cut, the Boston, Massachusetts-based biotech said mavorixafor, which X4 (XFOR) markets asContinue Reading
